TNFTNFRSF1A, and TNFRSF1B variants affect TNFR1 and TNFR2 levels in patients with severe COVID-19
I. Fricke-Galindo (Mexico City, Mexico), I. Buendía-Roldán (Mexico City, Mexico), L. Chávez-Galán (Mexico City, Mexico), G. Pérez-Rubio (Mexico City, Mexico), A. Ruiz (Mexico City, Mexico), Y. Palacios-Rodríguez (Mexico City, Mexico), R. Hernández-Zenteno (Mexico City, Mexico), R. Falfán-Valencia (Mexico City, Mexico)
Source: International Congress 2022 – New mechanistic insights into acute and chronic interstitial lung disorders
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Fricke-Galindo (Mexico City, Mexico), I. Buendía-Roldán (Mexico City, Mexico), L. Chávez-Galán (Mexico City, Mexico), G. Pérez-Rubio (Mexico City, Mexico), A. Ruiz (Mexico City, Mexico), Y. Palacios-Rodríguez (Mexico City, Mexico), R. Hernández-Zenteno (Mexico City, Mexico), R. Falfán-Valencia (Mexico City, Mexico). TNFTNFRSF1A, and TNFRSF1B variants affect TNFR1 and TNFR2 levels in patients with severe COVID-19. 2801
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|